NeuBase Therapeutics Inc.

The momentum for this stock is not very good. NeuBase Therapeutics Inc. is not a good value stock. NeuBase Therapeutics Inc. is not very popular among insiders. NeuBase Therapeutics Inc. is a mediocre stock to choose.
Log in to see more information.

News

NeuBase Therapeutics shareholder meeting adjourns without dissolution approval
NeuBase Therapeutics shareholder meeting adjourns without dissolution approval

BizJournals.com - Nat'l Business News NeuBase Therapeutics said Monday that its special shareholder meeting to approve its dissolution adjourned without approval and will reconvene later this month after seeking more votes.\n more…

NeuBase Therapeutics to delist from Nasdaq next week
NeuBase Therapeutics to delist from Nasdaq next week

Bizjournals.com - Health Care News Pittsburgh-based biotech firm NeuBase Therapeutics, which is in the process of dissolving, will be removed from the Nasdaq stock exchange May 13.\n more…

NeuBase Therapeutics announces receipt of Nasdaq notice
NeuBase Therapeutics announces receipt of Nasdaq notice

Seeking Alpha - Healthcare NeuBase Therapeutics announces receipt of Nasdaq notice...\n more…

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq

Globe Newswire PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ( NeuBase or the Company ) today reported that it received a notice (the Notice) on April 4, 2024 from...\n more…

Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nNeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.\nThe...\n more…

NeuBase Therapeutics sets shareholder meeting on dissolution plan
NeuBase Therapeutics sets shareholder meeting on dissolution plan

Bizjournals.com - Health Care News NeuBase Therapeutics will hold a special shareholder meeting May 13 to approve a plan to liquidate and dissolve the Pittsburgh biotech firm.\n more…